Amgen suffers setback as patent office refuses to review competitor’s drug
The U.S. Patent and Trademark Office handed Amgen a potential setback Jan. 14 when it declined to review two patent expiration dates on a competitor’s drug. In June, Thousand Oaks-based biotech giant Amgen asked the agency to review two formulation patents for Humira, made by Chicago-based competitor AbbVie, arguing that the patents should not have Read More →
Limoneira misses Wall Street expectations for fourth quarter
Santa Paula-based Limoneira Co. reported fiscal fourth-quarter net income of $654,000 on Jan. 11 after reporting a loss in the same period a year earlier. The company said it had profit of 4 cents per share. Losses, adjusted for non-recurring gains, came to 23 cents per share. The results did not meet Wall Street expectations. Read More →
Shire acquiring Baxalta for $32 billion
Shire PLC sweetened the pot and Baxalta Inc. investors took the bait in a deal announced early Jan. 11. Dublin-based Shire announced a $30 billion bid for Deefield, Ill.-based Baxalta on Aug. 4. On Jan. 11, the companies announced Shire will acquire Baxalta for $32 billion. Baxalta employs about 2,000 people in Thousand Oaks and Read More →
San Francisco Federal Reserve Bank CEO says he’s bullish on U.S. economy at Santa Barbara event
All in all, things are looking good for the U.S. economy, Federal Reserve Bank of San Francisco President and CEO John Williams said in Santa Barbara the morning of Jan. 8. Despite China’s market uncertainty and the global volatility, Williams doesn’t expect that to have a major impact on the U.S. economy. He pointed Read More →
Sientra implants could be back on the market in weeks
Sientra made three major announcements on Jan. 7: It is not yet resuming production at its factory in Rio de Janeiro, it is looking for a new manufacturer of its implants and the existing inventory could be back on the market within weeks. On Jan. 8, the British Medicines and Healthcare Products Regulatory Agency also Read More →
Surgeons clamor for Sientra implants
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Coast National sale speeds up merger surge
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
